Other OTC - Delayed Quote USD

Vasamed, Inc. (VSMD)

0.0000 0.0000 (0.00%)
As of January 26 at 11:13 AM EST. Market Open.

Key Executives

Amounts are as of December 31, 2004 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Ms. Paulita M. LaPlante VP & Director 180k -- 1958
Mr. Michael Schreiber President & CEO -- -- --
Ms. Roberta L. Dircks Chief Financial Officer and Vice President of Finance & Administration -- -- 1945
Mr. Daniel Bartnik CTO & VP of Operations -- -- --

Vasamed, Inc.

7615 Golden Triangle Drive
Suite A
Eden Prairie, MN 55344
United States
952-944-5857 https://www.vasamed.com
Sector: 
Healthcare

Description

Vasamed Incorporated designs, licenses, manufactures, and distributes products, software, and services for assessing and managing hemodynamic health in the United States. It offers SensiLase PAD-IQ, which supports skin perfusion pressure, pulse volume recording, and ankle brachial index calculation for Doppler-obtained pressures; and Wound Imaging & SmartDraw wound measurement systems. The company also provides PAD-IQ Studycast that provides rapid transmission of diagnostic tests to vascular specialist for interpretation of results and medically indicated therapeutic intervention; and custom carrying case to secure and protect the PAD-IQ system. It serves clinicians and patients. The company was founded in 1988 and is headquartered in Eden Prairie, Minnesota.

Corporate Governance

Vasamed, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events